Free Trial

Basel Medical Group (BMGL) Competitors

$4.17 +0.10 (+2.46%)
As of 05/2/2025 03:59 PM Eastern

BMGL vs. VMD, DCGO, TOI, AIRS, CORBF, ATPC, XGN, SERA, QIPT, and EUDA

Should you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Viemed Healthcare (VMD), DocGo (DCGO), Oncology Institute (TOI), AirSculpt Technologies (AIRS), Global Cord Blood (CORBF), Agape ATP (ATPC), Exagen (XGN), Sera Prognostics (SERA), Quipt Home Medical (QIPT), and EUDA Health (EUDA). These companies are all part of the "healthcare" industry.

Basel Medical Group vs.

Basel Medical Group (NASDAQ:BMGL) and Viemed Healthcare (NASDAQ:VMD) are both small-cap services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.

Viemed Healthcare received 3 more outperform votes than Basel Medical Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Basel Medical GroupN/AN/A
Viemed HealthcareOutperform Votes
3
42.86%
Underperform Votes
4
57.14%

In the previous week, Viemed Healthcare had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 3 mentions for Viemed Healthcare and 2 mentions for Basel Medical Group. Viemed Healthcare's average media sentiment score of 1.60 beat Basel Medical Group's score of 1.29 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Basel Medical Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Viemed Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Basel Medical Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Viemed Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Viemed Healthcare has higher revenue and earnings than Basel Medical Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Basel Medical Group$10.05M7.66N/AN/AN/A
Viemed Healthcare$224.26M1.30$10.24M$0.2826.32

Viemed Healthcare has a net margin of 4.87% compared to Basel Medical Group's net margin of 0.00%. Viemed Healthcare's return on equity of 8.72% beat Basel Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Basel Medical GroupN/A N/A N/A
Viemed Healthcare 4.87%8.72%6.48%

Summary

Viemed Healthcare beats Basel Medical Group on 11 of the 12 factors compared between the two stocks.

Get Basel Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BMGL vs. The Competition

MetricBasel Medical GroupServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$76.96M$43.43M$2.37B$8.04B
Dividend YieldN/AN/AN/A4.22%
P/E RatioN/AN/A2.1618.83
Price / Sales7.667.6620.80106.72
Price / CashN/AN/AN/A34.62
Price / BookN/AN/AN/A4.33
Net IncomeN/A-$40,000.00N/A$247.97M
7 Day Performance-3.70%-0.62%49.28%3.18%
1 Month PerformanceN/AN/A4.67%8.13%
1 Year PerformanceN/AN/A212.82%5.01%

Basel Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMGL
Basel Medical Group
N/A$4.17
+2.5%
N/AN/A$76.96M$10.05M0.0036Positive News
VMD
Viemed Healthcare
1.7599 of 5 stars
$7.13
+0.9%
N/A-10.0%$282.04M$224.26M26.43630Upcoming Earnings
Short Interest ↓
Positive News
DCGO
DocGo
2.5512 of 5 stars
$2.22
+0.7%
$4.89
+120.8%
-34.2%$225.38M$616.56M7.892,920Upcoming Earnings
Positive News
TOI
Oncology Institute
0.6924 of 5 stars
$2.73
-2.2%
N/A+141.4%$208.92M$393.41M-3.54660News Coverage
AIRS
AirSculpt Technologies
0.9737 of 5 stars
$2.73
+20.6%
$3.75
+37.6%
-45.1%$152.94M$180.35M-18.65240News Coverage
Gap Up
CORBF
Global Cord Blood
N/A$1.06
+1.0%
N/A-15.2%$128.84M$196.12M0.001,200Gap Up
ATPC
Agape ATP
0.3267 of 5 stars
$2.29
-2.1%
N/A-67.4%$114.51M$1.32M-3.1440
XGN
Exagen
4.0941 of 5 stars
$6.19
+0.8%
$7.50
+21.2%
+336.2%$110.74M$55.64M-6.58220Positive News
Gap Up
SERA
Sera Prognostics
1.0732 of 5 stars
$3.03
+3.1%
N/A-72.6%$110.54M$77,000.00-2.96120Short Interest ↓
News Coverage
Gap Down
QIPT
Quipt Home Medical
2.1592 of 5 stars
$2.16
+0.4%
$6.25
+189.5%
-45.9%$92.60M$244.72M-12.64800
EUDA
EUDA Health
1.1177 of 5 stars
$3.70
-1.0%
N/A+108.5%$91.22M$3.81M0.002Upcoming Earnings
News Coverage

Related Companies and Tools


This page (NASDAQ:BMGL) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners